DEH-18576-94134
3 vaccinations
2 coded responses
30 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 303 / GA
- Registered
- 2020-12-19
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- N/A
Timeline
-
2020-12-19
Registered in v-safe
-
2020-12-19
Dose 1 — Pfizer-BioNTech
- 2020-12-19
-
2020-12-20
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Chills, Headache, Fatigue or tirednessAdult check-in
- 2020-12-21
- 2020-12-22
- 2020-12-23
- 2020-12-24
- 2020-12-25
- 2021-01-02
-
2021-01-09
Dose 2 — Pfizer-BioNTech
- 2021-01-09
-
2021-01-10
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-15
- 2021-01-18
- 2021-01-23
- 2021-01-30
- 2021-02-13
- 2021-02-20
- 2021-04-10
- 2021-07-10
-
2021-09-29
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2021-10-01
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
-
2021-10-02
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-10-03
- 2021-10-04
- 2021-10-08
- 2021-10-13
- 2021-10-20
- 2021-10-27
- 2021-11-03
- 2021-11-10
-
2021-12-31
Survey response — 3 months, dose 3MedDRA: Cough, Headache, Pain, Sneezing — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Cough and body aches headache and sneezingMedDRA releases: 2024-11 · check-in free text available
-
2021-12-31
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-01-06
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-03-30
Survey response — 6 months, dose 3MedDRA: Cough, Paranasal sinus discomfort — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Cough and sinus pressureMedDRA releases: 2024-11 · check-in free text available
-
2022-03-30
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-03-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-19 | Pfizer-BioNTech | |
| 2 | 2021-01-09 | Pfizer-BioNTech | |
| 3 | 2021-09-29 | Pfizer-BioNTech | Flu |
Call center
2 call center cases
1 successful · 1 unsuccessful
Free text
Release 10 — 3 months, dose 3
Symptoms: Cough and body aches headache and sneezing
Release 11 — 6 months, dose 3
Symptoms: Cough and sinus pressure
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Paranasal sinus discomfort | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release